DK523277A - PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH PROTRADE EFFECT - Google Patents

PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH PROTRADE EFFECT

Info

Publication number
DK523277A
DK523277A DK523277A DK523277A DK523277A DK 523277 A DK523277 A DK 523277A DK 523277 A DK523277 A DK 523277A DK 523277 A DK523277 A DK 523277A DK 523277 A DK523277 A DK 523277A
Authority
DK
Denmark
Prior art keywords
preparation
protrade
procedure
effect
pharmaceutical
Prior art date
Application number
DK523277A
Other languages
Danish (da)
Other versions
DK150534B (en
DK150534C (en
Inventor
Y Raghunathan
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of DK523277A publication Critical patent/DK523277A/en
Publication of DK150534B publication Critical patent/DK150534B/en
Application granted granted Critical
Publication of DK150534C publication Critical patent/DK150534C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK523277A 1976-11-26 1977-11-25 PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION WITH DELAYED DELIVERY OF AN ACTIVE INGREDIENT DK150534C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US74532576 1976-11-26
US80010577A 1977-05-24 1977-05-24
US80010577 1977-05-24

Publications (3)

Publication Number Publication Date
DK523277A true DK523277A (en) 1978-05-27
DK150534B DK150534B (en) 1987-03-23
DK150534C DK150534C (en) 1987-10-12

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
DK523277A DK150534C (en) 1976-11-26 1977-11-25 PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION WITH DELAYED DELIVERY OF AN ACTIVE INGREDIENT

Country Status (21)

Country Link
JP (1) JPS609697B2 (en)
AR (1) AR218047A1 (en)
AT (1) AT359197B (en)
AU (1) AU511080B2 (en)
BE (1) BE861141A (en)
CA (1) CA1086226A (en)
CH (1) CH639560A5 (en)
DE (1) DE2752728C2 (en)
DK (1) DK150534C (en)
FI (1) FI65910C (en)
FR (1) FR2373288A1 (en)
GB (1) GB1544761A (en)
GR (1) GR61724B (en)
IE (1) IE45998B1 (en)
IL (1) IL53462A (en)
LU (1) LU78584A1 (en)
NL (1) NL182283C (en)
NO (1) NO147626C (en)
NZ (1) NZ185772A (en)
PT (1) PT67323B (en)
SE (1) SE426781B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (en) 1979-07-20 1981-02-05 Lentia Gmbh COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
EP0542926B1 (en) * 1990-08-07 1995-02-15 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (en) * 2016-12-08 2019-03-22 Salsarulo Pharma ORAL MEDICINE COMPRISING AN OSMOTIC LAXATIVE INCORPORATED IN A MATRIX BASED ON VEGETABLE FATS
CA3078844A1 (en) * 2017-10-09 2019-04-18 Rhodes Pharmaceuticals L.P. Pharmaceutical resinate compositions and methods of making and using thereof
CN113811488B (en) * 2019-05-23 2024-05-03 吉第联合股份公司 Filling unit for filling containers with liquid products of the pharmaceutical industry

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (en) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
DE2343218C2 (en) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Pellets containing furosemide

Also Published As

Publication number Publication date
FR2373288A1 (en) 1978-07-07
JPS5369822A (en) 1978-06-21
JPS609697B2 (en) 1985-03-12
DK150534B (en) 1987-03-23
DE2752728A1 (en) 1978-06-01
CH639560A5 (en) 1983-11-30
DE2752728C2 (en) 1985-08-01
NO774051L (en) 1978-05-29
SE7713370L (en) 1978-05-27
NL182283C (en) 1988-02-16
NO147626C (en) 1983-05-25
IL53462A0 (en) 1978-01-31
IE45998L (en) 1978-05-26
IL53462A (en) 1980-12-31
BE861141A (en) 1978-03-16
IE45998B1 (en) 1983-01-26
CA1086226A (en) 1980-09-23
GR61724B (en) 1978-12-29
ATA848077A (en) 1980-03-15
FI773568A (en) 1978-05-27
FR2373288B1 (en) 1980-06-13
AU3098677A (en) 1979-05-31
AU511080B2 (en) 1980-07-24
LU78584A1 (en) 1978-04-20
NO147626B (en) 1983-02-07
GB1544761A (en) 1979-04-25
NZ185772A (en) 1978-12-18
FI65910C (en) 1984-08-10
PT67323B (en) 1979-04-24
AT359197B (en) 1980-10-27
AR218047A1 (en) 1980-05-15
NL7712996A (en) 1978-05-30
NL182283B (en) 1987-09-16
PT67323A (en) 1977-12-01
FI65910B (en) 1984-04-30
SE426781B (en) 1983-02-14
DK150534C (en) 1987-10-12

Similar Documents

Publication Publication Date Title
DK371277A (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL DOSAGE FORMS WITH PERMANENT EFFECT
DK113676A (en) PROCEDURES FOR THE PREPARATION OF A RETARIAN
DK142372C (en) PROCEDURE FOR THE PREPARATION OF ANDROSTAN-17-ON DERIVATIVES
DK377A (en) PROCEDURE FOR THE PREPARATION OF N-PHOSPHONOMETHYL-GLYCIN
DK244577A (en) PROCEDURE FOR THE PREPARATION OF HYDANTO INTERVENTIVES
DK334077A (en) PROCEDURE FOR THE PREPARATION OF A POLYSACCHARID
DK523277A (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH PROTRADE EFFECT
DK271977A (en) PROCEDURE FOR THE PREPARATION OF DISPEPTIDE DERIVATIVES
DK339677A (en) PROCEDURE FOR THE PREPARATION OF 2-BENZYLPYRROLIDINES
DK352578A (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION
DK118177A (en) PROCEDURE FOR THE PREPARATION OF ISOBUTYRAMID DERIVATIVES
DK46577A (en) PROCEDURE FOR THE PREPARATION OF TETRAHYDROECHINOCANDIN DERIVATIVES
DK144377A (en) PROCEDURE FOR THE PREPARATION OF ACYLCYANIDES
DK151878C (en) PROCEDURE FOR THE PREPARATION OF A 2-SUBSTITUTED BENZANILIDE
DK143173C (en) PROCEDURE FOR THE PREPARATION OF A URINUM-URINUM PHOSPHATE-SUBSTANCED DRUGS
DK144277A (en) PROCEDURE FOR THE PREPARATION OF ACYLCYANIDES
DK216977A (en) PROCEDURE FOR THE PREPARATION OF IMIDAZOBENZOXAZINES
DK264377A (en) PROCEDURE FOR THE PREPARATION OF 1ALFA-HYDROXYCHOLESTEROL DERIVATIVES
DK345277A (en) PROCEDURE FOR THE PREPARATION OF TETRAHYDROPYRIDINE DERIVATIVES
DK235277A (en) PROCEDURE FOR THE PREPARATION OF A POLYSACCHARID
DK538977A (en) PROCEDURE FOR THE PREPARATION OF 17ALFA-HYDROXY-21-ACETOXY-PROGESTERONE
DK196577A (en) PROCEDURE FOR THE PREPARATION OF CHOLECYSTOKININ-PANCREOZYMIN-OCTAPEPTIDAMIDE SULFATESTER
DK568278A (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION
DK301377A (en) PROCEDURE FOR THE PREPARATION OF CISHEXAHYDRODIBENZOPYRANONES
DK338677A (en) PROCEDURE FOR THE PREPARATION OF 3-ALCOXYCYPROHEPTADINES

Legal Events

Date Code Title Description
PUP Patent expired